Article Details

Roche Holding AG Announces Data from the Phase III OCARINA II Study (S31.006) of ...

Retrieved on: 2024-04-17 18:37:15

Tags for this article:

Click the tags to see associated articles and topics

Roche Holding AG Announces Data from the Phase III OCARINA II Study (S31.006) of .... View article details on hiswai:

Excerpt

Both the European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) have accepted Roche?s submissions, with a target decision date of ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo